Controversies of hepatectomy and adjuvant therapy for hepatocellular carcinoma: moving forward

摘要

Due to the prevelence of hepatitis B virus (HBV) and hepatitis C virus (HCV), occurrence of hepatocellular carcinoma (HCC) is increasing in many countries/regions, including China[1].